DNATRIX INC has a total of 48 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2006. It filed its patents most often in United States, EPO (European Patent Office) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are PRO VIRUS INC, SCHWEITZER CHEMICAL CORP USA and THE GOVERNMENT OF THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | EPO (European Patent Office) | 8 | |
#3 | China | 6 | |
#4 | Singapore | 6 | |
#5 | Canada | 4 | |
#6 | WIPO (World Intellectual Property Organization) | 4 | |
#7 | Hong Kong | 3 | |
#8 | Republic of Korea | 3 | |
#9 | Australia | 2 | |
#10 | Spain | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Analysing materials | |
#6 | Measuring microorganism processes | |
#7 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Tufaro Frank | 40 |
#2 | Conrad Charles | 34 |
#3 | Yung W K Alfred | 32 |
#4 | Fueyo-Margareto Juan | 24 |
#5 | Gomez-Manzano Candelaria | 23 |
#6 | Jiang Hong | 14 |
#7 | Lang Fred | 10 |
#8 | Heimberger Amy | 9 |
#9 | Fueyo Juan | 9 |
#10 | Manzano-Gomez Candeleria | 8 |
Publication | Filing date | Title |
---|---|---|
US2019275092A1 | Combination therapy for treatment of brain cancers | |
CN109789177A | Adenovirus and immunomodulatory agents treatment | |
CN106029889A | Adenovirus expressing immune cell stimulatory receptor agonist(s) | |
CN104427992A | Biomarkers and combination therapies using oncolytic virus and immunomodulation | |
ES2304281A1 | ADENOVIRUS ONCOLITICOS FOR THE TREATMENT OF CANCER. |